Your search for oral corticosteroids returned 229 results

The 10-step program assists clinicians in diagnosing and treating CDH.

Treatment with single-agent carfilzomib achieved durable responses in patients with relapsed/refractory multiple myeloma whose disease had relapsed after they received all available therapies (including bortezomib and immunomodulatory agents), suggesting that this agent has the potential to offer substantial clinical benefit. The data was presented at the 52nd American Society of Hematology Annual Meeting and Exposition.

Metastatic calcification of the left 
breast in a patient with renal failure 
raises suspicion.

Updated on 6/16 While no specific treatment for coronavirus disease 2019 (COVID-19) is currently available, several therapies are being investigated globally.*    AB201 (ARCA biopharma): a selective inhibitor of tissue factor being developed as a potential treatment for COVID associated coagulopathy. Clinical testing is expected to begin in the second half of 2020. Acalabrutinib (AstraZeneca): a…

An adolescent presented with persistent upper-extremity pain, redness, and 
axillary swelling upon lifting weights.

When treating an adult female patient with the chief complaint of alopecia, 
the clinician should pay particular attention to the pattern of hair loss.

In January, 2015, the Endocrine Society issued an evidence-based clinical practice guideline for the pharmacologic management of obesity (co-sponsored by the European Society of Endocrinology and the Obesity Society).

This CME/CEU activity is designed to give clinicians a better understanding of the pharmacology, indications, contraindications, benefits/risk and clinical trials data of a broad spectrum of new agents and those that have been granted a new indication.

Methods to prevent and treat COVID-19 in cancer patients have had to evolve alongside the SARS-CoV-2 virus.